GIM
IMGN

Granahan Investment Management’s Immunogen Inc IMGN Stock Holding History

Granahan Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-119,016
Closed -$3.53M – 200
2023
Q4 		$3.53M Sell
119,016
-562,361
-83% -$11.2M 0.12% 149
2023
Q3 		$10.8M Buy
681,377
+254,625
+60% +$4.23M 0.39% 81
2023
Q2 		$8.05M Sell
426,752
-438,014
-51% -$5.17M 0.25% 103
2023
Q1 		$3.32M Sell
864,766
-1,321,192
-60% -$5.63M 0.1% 143
2022
Q4 		$10.8M Buy
2,185,958
+308,998
+16% +$1.68M 0.33% 82
2022
Q3 		$8.97M Sell
1,876,960
-4,836
-0.3% -$25.5K 0.29% 94
2022
Q2 		$8.47M Sell
1,881,796
-75,923
-4% -$330K 0.29% 91
2022
Q1 		$9.32M Buy
1,957,719
+691,029
+55% +$3.83M 0.23% 98
2021
Q4 		$9.4M Buy
1,266,690
+589,072
+87% +$3.66M 0.19% 116
2021
Q3 		$3.84M Buy
+677,618
New +$3.92M 0.07% 166
2015
Q4 		– Sell
-401,000
Closed -$3.85M – 253
2015
Q3 		$3.85M Sell
401,000
-18,000
-4% -$263K 0.12% 196
2015
Q2 		$6.03M Hold
419,000
– – 0.17% 166
2015
Q1 		$3.75M Buy
419,000
+5,200
+1% +$37.7K 0.11% 189
2014
Q4 		$2.52M Sell
413,800
-106,532
-20% -$974K 0.07% 188
2014
Q3 		$5.51M Sell
520,332
-720
-0.1% -$8.14K 0.17% 156
2014
Q2 		$6.17M Sell
521,052
-19,589
-4% -$246K 0.18% 154
2014
Q1 		$8.07M Sell
540,641
-594,760
-52% -$9.38M 0.22% 149
2013
Q4 		$16.7M Buy
1,135,401
+36,171
+3% +$556K 0.43% 93
2013
Q3 		$18.7M Sell
1,099,230
-56,770
-5% -$998K 0.5% 79
2013
Q2 		$19.2M Buy
+1,156,000
New +$18.7M 0.55% 69

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Granahan Investment Management's IMGN Position: Q1 2024 in Review

Granahan Investment Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 119,016 shares — an estimated $3.53M sold.

Granahan Investment Management first reported a position in IMGN in Q2 2013 and held it in 20 quarters. The position peaked at $19.2M in Q2 2013. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Granahan Investment Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Granahan Investment Management sold 119,016 Immunogen Inc shares in Q1 2024, an estimated $3.53M.
  • Granahan Investment Management first reported a position in Immunogen Inc in Q2 2013 and held it in 20 quarters.
  • Granahan Investment Management's Immunogen Inc position peaked at $19.2M in Q2 2013.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Granahan Investment Management's 13F filing for Q1 2024, filed 15 May 2024.